Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
15,106
Frequently Asked Questions
What is Market Cap of Regeneron Pharmaceuticals, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Regeneron Pharmaceuticals, Inc. market cap is $59.59B.
What is the 52-week high for Regeneron Pharmaceuticals, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Regeneron Pharmaceuticals, Inc. 52 week high is $1,045.95 as of October 01, 2025.
What is the 52-week low for Regeneron Pharmaceuticals, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Regeneron Pharmaceuticals, Inc. 52 week low is $476.49 as of October 01, 2025.
What is Regeneron Pharmaceuticals, Inc. stock price today?
Regeneron Pharmaceuticals, Inc. stock price today is $603.64.
What was Regeneron Pharmaceuticals, Inc. stock price yesterday?
Regeneron Pharmaceuticals, Inc. stock price yesterday was $562.27.
What is the PE ratio of Regeneron Pharmaceuticals, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Regeneron Pharmaceuticals, Inc.’s P/E ratio is 14.17.
What is the Price-to-Book ratio of Regeneron Pharmaceuticals, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Regeneron Pharmaceuticals, Inc. P/B ratio is 1.9983.
What is the 50-day moving average of Regeneron Pharmaceuticals, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Regeneron Pharmaceuticals, Inc. 50-day moving average is $569.73.
How many employess does Regeneron Pharmaceuticals, Inc. has?
Regeneron Pharmaceuticals, Inc. has 15,106 employees.
REGN Regeneron Pharmaceuticals, Inc.